TY  - JOUR
AU  - Rivera-Izquierdo, Mario
AU  - Morales-Portillo, Arturo
AU  - Guerrero-Fernández de Alba, Inmaculada
AU  - Fernández-Martínez, Nicolás Francisco
AU  - Schoenenberger-Arnaiz, Joan Antoni
AU  - Barranco-Quintana, José Luis
AU  - Valero-Ubierna, Carmen
PY  - 2024
DO  - 10.1080/14760584.2024.2401839
SN  - 1476-0584
UR  - https://hdl.handle.net/10668/24290
T2  - Expert review of vaccines.
AB  - Introduction: Monoclonal antibodies (mAbs) and other biological agents are being increasingly approved in the last years with very different indications. Their highly heterogeneous immunosuppressive effects, mechanisms of action and pharmacokinetics...
LA  - en
PB  - Taylor & Francis
KW  - Biologic therapy
KW  - biologics
KW  - immunosuppression
KW  - mAbs
KW  - nirsevimab
KW  - vaccine
KW  - vaccine schedule
KW  - Biological Therapy
KW  - Immunocompromised Host
KW  - Vaccination
KW  - Antibodies, Monoclonal
TI  - Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024.
TY  - research article
VL  - 23
ER  -